Sehn LH, Salles G. Diffuse large B-Cell lymphoma. N Engl J Med. 2021;384(9):842–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47–53.

Article  PubMed  PubMed Central  Google Scholar 

Lopez-Santillan M, Lopez-Lopez E, Alvarez-Gonzalez P, Martinez G, Arzuaga-Mendez J, Ruiz-Diaz I, Guerra-Merino I, Gutierrez-Camino A, Martin-Guerrero I. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: a systematic review. Crit Rev Oncol/Hematol. 2021;165:103430.

Article  PubMed  Google Scholar 

Moore DC, Peery MR, Tobon KA, Raheem F, Hwang GS, Alhennawi L, Hughes ME. New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma. J Oncol Pharm Practice: Official Publication Int Soc Oncol Pharm Practitioners. 2022;28(8):1848–58.

Article  CAS  Google Scholar 

Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, Christian B, Lepage E, Tilly H, Morschhauser F, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude Des Lymphomes De l’Adulte. J Clin Oncology: Official J Am Soc Clin Oncol. 2005;23(18):4117–26.

Article  CAS  Google Scholar 

Harris LJ, Patel K, Martin M. Novel therapies for relapsed or refractory diffuse large B-Cell lymphoma. Int J Mol Sci 2020, 21(22).

Melchardt T, Egle A, Greil R. How I treat diffuse large B-cell lymphoma. ESMO open. 2023;8(1):100750.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Argilés JM. Cancer-associated malnutrition. Eur J Oncol Nursing: Official J Eur Oncol Nurs Soc. 2005;9(Suppl 2):S39–50.

Article  Google Scholar 

Taguchi S, Kawai T, Nakagawa T, Nakamura Y, Kamei J, Obinata D, Yamaguchi K, Kaneko T, Kakutani S, Tokunaga M et al. Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study. Scientific Reports 2021, 11(1).

Abe A, Hayashi H, Ishihama T, Furuta H. Prognostic impact of the prognostic nutritional index in cases of resected oral squamous cell carcinoma: a retrospective study. BMC Oral Health 2021, 21(1).

An S, Han GY, Eo W, Kim DH, Lee S. Comparison of the geriatric nutritional risk index and the prognostic nutritional index in determining survival outcome in patients with non-small cell lung cancer undergoing surgical resection: a cohort study. Med (Baltim). 2022;101(45):e31591.

Article  CAS  Google Scholar 

Sun H, Ma J, Lu J, Yao ZH, Ran HL, Zhou H, Yuan ZQ, Huang YC, Xiao YY. Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma. World J Gastrointest Oncol. 2023;15(9):1662–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Liao X, Xie Z, Li H. Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: a meta-analysis. Med (Baltim). 2023;102(19):e33663.

Article  Google Scholar 

Xu X, Tian M, Ding CC, Xu H, Wang H, Jin X. Skeletal muscle index-based Cachexia Index as a predictor of prognosis in patients with Cancer: a Meta-analysis and systematic review. Nutr Rev 2024;nuae094.

Liu W, Li M, Lian S, Hou X, Ling Y. Geriatric nutritional risk index as a predictor for postoperative complications in patients with solid cancers: a meta-analysis. Front Oncol. 2024;14:1266291.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu XT, Qian Y, Tian MX, Ding CC, Guo H, Tang J, Pi GL, Wu Y, Dai Z, Jin X. Predictive impact of Prognostic Nutritional Index in patients with Cancer treated with Immune Checkpoint inhibitors: a systematic review and Meta-analysis. Nutr Cancer. 2023;75(6):1413–26.

Article  CAS  PubMed  Google Scholar 

Roberts WS, Delladio W, Price S, Murawski A, Nguyen H. The efficacy of albumin-globulin ratio to predict prognosis in cancer patients. Int J Clin Oncol. 2023;28(9):1101–11.

Article  CAS  PubMed  Google Scholar 

Li B, Deng H, Lei B, Chen L, Zhang X, Sha D. The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: a meta-analysis. Front Oncol. 2022;12:985377.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, Rodríguez F. Fernández G: CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38–45.

PubMed  Google Scholar 

Miyazaki R, Tamura M, Sakai T, Furukawa N, Yamamoto M, Okada H. Using the combined C-reactive protein and controlling nutritional status index for elderly non-small cell lung cancer. J Thorac Dis. 2024;16(7):4400–8.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Kong LZ. Prognostic value of the Controlling Nutritional Status score in patients with newly diagnosed multiple myeloma. Am J Transl Res. 2024;16(9):4788–95.

Article  PubMed  PubMed Central  Google Scholar 

Li SY, Wan LL, Liu YF, Li YW, Huang X, Liu RJ. Prognostic value of three clinical nutrition scoring system (NRI, PNI, and CONUT) in elderly patients with prostate cancer. Front Nutr. 2024;11:1436063.

Article  PubMed  PubMed Central  Google Scholar 

Fu J, Xu X, Tian M, Wang H, Jin X. The controlling nutritional status score as a new prognostic predictor in patients with cervical cancer receiving radiotherapy: a propensity score matching analysis. BMC Cancer. 2024;24(1):1093.

Article  PubMed  PubMed Central  Google Scholar 

Boltri M, Traunero F, Ongaro L, Migliozzi F, Vianello F, Lenardon O, Visalli F, Buttazzi L, Maruzzi D, Trombetta C et al. The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma. Cancers (Basel) 2024, 16(20).

Matsukawa T, Suto K, Kanaya M, Izumiyama K, Minauchi K, Yoshida S, Oda H, Miyagishima T, Mori A, Ota S, et al. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol. 2020;99(12):2859–68.

Article  PubMed  Google Scholar 

Nagata A, Kanemasa Y, Sasaki Y, Nakamura S, Okuya T, Funasaka C, Kageyama A, Shimoyama T, Omuro Y. Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma. Hematol Oncol. 2020;38(3):309–17.

Article  CAS  PubMed  Google Scholar 

Akgün Çağlıyan G, Hacıoğlu S, Ünver Koluman B, İlkkılıç K, Nar R, Başer MN, Bozdemir A, Şenol H, Şen Türk N, Erol V, et al. Is CONUT score a prognostic index in patients with diffuse large cell lymphoma? Turk J Med Sci. 2021;51(4):2112–9.

Article  PubMed  PubMed Central  Google Scholar 

Baysal M, Bas V, Demirci U, Gulsaran SK, Umit E, Kirkizlar HO, Demir AM. The utility of CONUT score in diffuse large B cell lymphoma patients. Niger J Clin Pract. 2021;24(8):1194–9.

Article  CAS  PubMed  Google Scholar 

Yao J, Zhou S, Gao H, Chen R. The value of CONUT score in predicting the prognosis of patients with diffuse large B-cell lymphoma undergoing chemotherapy. Chin J Clin. 2021;49(12):1442–4.

Google Scholar 

Go SI, Choi BH, Park MJ, Park S, Kang MH, Kim HG, Kang JH, Jeong EJ, Lee GW. Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell lymphoma. BMC Cancer. 2023;23(1):1071.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaneda Y, Kanemura N, Nakamura N, Ikoma Y, Yamaguchi K, Takada E, Shibata Y, Lee S, Fujita K, Morishita T, et al. The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2024;65(3):339–45.

Article  CAS  PubMed  Google Scholar 

Shan H, Chen X, Zhang H, Miao Y, Wang F, Shi Y, Wang L, Ye J, Shen Z, Sang W, et al. Predictive value of controlling nutritional status score in the prognosis of patients with advanced diffuse large B-cell lymphoma. J Leuk Lymphoma. 2024;33(2):104–9.

Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

Article  PubMed  PubMed Central  Google Scholar 

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

Article  PubMed  Google Scholar 

Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359(22):2313–23.

Article  CAS  PubMed  PubMed Central